Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000522776 | SCV000619438 | pathogenic | not provided | 2025-02-13 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge |
Ce |
RCV000522776 | SCV001150899 | likely pathogenic | not provided | 2018-10-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001223320 | SCV001395462 | pathogenic | KBG syndrome | 2023-11-27 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg2328Profs*204) in the ANKRD11 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ANKRD11 are known to be pathogenic (PMID: 21782149, 25125236, 25413698, 25652421). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ANKRD11-related conditions. ClinVar contains an entry for this variant (Variation ID: 450818). For these reasons, this variant has been classified as Pathogenic. |
Genetic Services Laboratory, |
RCV000522776 | SCV002064428 | pathogenic | not provided | 2017-07-05 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001223320 | SCV003815409 | likely pathogenic | KBG syndrome | 2022-03-18 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV001223320 | SCV005687789 | pathogenic | KBG syndrome | 2024-12-30 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV001249518 | SCV001423508 | pathogenic | Intellectual disability | 2019-12-01 | no assertion criteria provided | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV000522776 | SCV001800774 | likely pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000522776 | SCV001809670 | pathogenic | not provided | no assertion criteria provided | clinical testing |